Sequence addresses the biological factors that can prevent weight loss.
*20.9% weight loss in 68 weeks. Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.
* Your Sequence program includes the cost of labs and non-GLP-1 medications. The cost of GLP-1 medications is subject to insurance coverage. Your Care Team will help you with insurance coverage.
*Statements reference the GLP-1 class of medications